Ophthalmology Search
Ophthalmology Ophthalmology
primary%20open-angle%20glaucoma
PRIMARY OPEN-ANGLE GLAUCOMA
Primary open-angle glaucoma (POAG) is a chronic, progressive, usually bilateral disease of the eye with an insidious onset.
It is most often characterized by optic nerve damage, defects in the retinal fiber layer and subsequent visual field loss in the absence of underlying ocular disease or congenital abnormalities.
It is generally asymptomatic until it has caused a significant loss of visual field.
Occasionally, patients with very high intraocular pressure may complain of nonspecific headache, discomfort, intermittent blurring of vision or even halos caused by corneal edema.

History

  • Review of history of family, ocular & systemic diseases (eg DM, hypertension, asthma, vascular disorders) are obtained during initial evaluation
  • Current medications (ocular & systemic) being taken & history of adverse reactions to these drugs
  • History of eye surgery
    • Cataract surgery, photorefractive keratectomy may result in a falsely low intraocular pressure (IOP)
  • Ocular trauma (eg contusion)

Physical Examination

Visual Acuity

  • Measure & determine best corrected near & distance visual acuity

Examination of Pupils

  • Examine for reactivity & presence of afferent pupillary defect

Examination of the Fundus

  • Look for cupping, macular degeneration, disc edema, retinovascular occlusion, optic nerve pallor & pits
    • Cupping is the hallowing out of the optic nerve or “disc” & a diameter of >50% of the vertical disc signifies glaucoma

Imaging

Biomicroscopy

  • Assess the anterior chamber depth & angle, look for corneal defects, iris pathology or inflammation using slit-lamp biomicroscope to help determine for presence of a secondary cause of intraocular pressure (IOP) elevation

Tonometry

  • Bilateral measurement of IOP using Goldmann applanation tonometry done at varying times of the day or on different days to detect fluctuations
  • It is recommended to measure untreated IOP more than once prior to starting treatment

Gonioscopy

  • Important to exclude secondary causes of IOP (eg peripheral anterior synechiae, angle neovascularization, angle recession, etc) or exclude diagnosis of angle closure

Examination of Optic Nerve Head & Retinal Nerve Fiber Layer

  • Changes in these structures often precede visual field loss in glaucoma patients
    • Look for changes such as optic disc hemorrhages, peripapillary choroidal atrophy 
  • Performed using magnified stereoscopic visualization, digital photography & stereophotographic techniques w/ red-free illumination

Other Tests

  • Central corneal thickness (CCT) measurement (pachymetry) - helps to determine level of risk for ocular damage
  • Visual Field Test (eg Automated static threshold perimetry, short-wavelength automated perimetry or SWAP, frequency doubling technology or FDT)
  • Optical Coherence Tomography (OCT), Heidelberg Retinal Tomogram (HRT) & scanning laser polarimetry - for early detection of nerve fiber layer thinning
Editor's Recommendations
Most Read Articles
LVADs reverse pulmonary hypertension secondary to left heart disease
Tristan Manalac, 6 days ago
Left ventricular assist devices (LVADs) can reverse pulmonary hypertension secondary to left heart disease regardless of baseline pulmonary vascular resistance, according to a new study.
Acute kidney injury common in kids with cancer
11 May 2019
Acute kidney injury (AKI) commonly occurs within a year after cancer diagnosis in paediatric patients and is tied to long-term deteriorations in renal function, a recent study has found.
Prolonged exclusive breastfeeding promotes weight loss in mothers
11 May 2019
Women practicing exclusive breastfeeding for 6 months achieve greater postpartum weight loss compared with those exclusively breastfeeding for a shorter duration, according to data from the MILK* study.
Medical nutrition therapy is the key to unlocking betters diabetes control and improving patient outcomes
14 May 2019
At the recent GLYCEMIC GUARDIANS™ dinner symposium, three eminent speakers spoke on theindispensable role of medical nutrition therapy (MNT) in improving outcomes for patients with type2 diabetes (T2D).